KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Neogenomics (NEO) over the last 17 years, with Q4 2025 value amounting to 0.53.

  • Neogenomics' Asset Utilization Ratio rose 3203.29% to 0.53 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.53, marking a year-over-year increase of 3203.29%. This contributed to the annual value of 0.49 for FY2025, which is 2191.19% up from last year.
  • Neogenomics' Asset Utilization Ratio amounted to 0.53 in Q4 2025, which was up 3203.29% from 0.51 recorded in Q3 2025.
  • Neogenomics' 5-year Asset Utilization Ratio high stood at 0.6 for Q1 2021, and its period low was 0.25 during Q3 2021.
  • Over the past 5 years, Neogenomics' median Asset Utilization Ratio value was 0.35 (recorded in 2023), while the average stood at 0.36.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 7145.85% in 2021, then soared by 3203.29% in 2025.
  • Over the past 5 years, Neogenomics' Asset Utilization Ratio (Quarter) stood at 0.26 in 2021, then grew by 13.69% to 0.29 in 2022, then rose by 20.77% to 0.35 in 2023, then increased by 14.38% to 0.4 in 2024, then surged by 32.03% to 0.53 in 2025.
  • Its last three reported values are 0.53 in Q4 2025, 0.51 for Q3 2025, and 0.46 during Q2 2025.